SPHERA FUNDS MANAGEMENT LTD.
TEL AVIV, L3 · CIK 1496201 · 13F filing filed 2023-08-14
Exempt reporting adviser since 2021 · other (specify)
- Private funds1 (1 hedge) · $849.7m gross assets
- Websitespherafund.com
- Form ADV · 2026-03-17SEC adviser record
- Legal entityספרה ניהול קרנות בע"מ (IL)
- Kindhedge funds
- Others nearbyTel Aviv
As an employer
- Offices in1 country
- Private fundshedge 1
$466.6m
reported value
+1.0% vs Q1 2023
76positions
35.9%in top 10
18 new
16 added
23 reduced
17 sold out
vs Q1 2023
Options: 8 call positions ($111.0m notional), 3 put positions ($62.9m notional) – listed below, not included above.
This report includes the holdings of 2 other managers that share the investment decisions:
- Sphera Global Healthcare GP Ltd. – reports through this filing
- Sphera Global Healthcare Management LP – reports through this filing
Shares in two reports are counted once in each security's totals.
Holdings, Q2 2023
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| SANOFI SNY | $28.5m6.12% | Unchanged |
| ASTRAZENECA PLC SPONSORED ADR | $20.4m4.37% | Unchanged |
| JOHNSON & JOHNSON JNJ | $19.8m4.25% | Unchanged |
| NICE LTD NICE | $18.1m3.87% | Reduced -28.0k |
| AMAZON COM INC AMZN | $16.2m3.47% | Added +38.6k |
| SYNDAX PHARMACEUTICALS INC SNDX | $15.1m3.24% | Added +40.0k |
| MERCK & CO INC MRK | $13.9m2.98% | Unchanged |
| ENPHASE ENERGY INC ENPH 0 03.01.28 | $13.4m2.88% | Added +3.6m |
| MICROSOFT CORP MSFT | $11.7m2.50% | Reduced -20.3k |
| PRAXIS PRECISION MEDICINES I COM | $10.1m2.16% | New |
| NOVO-NORDISK A S NVO | $9.1m1.96% | Reduced -15.0k |
| POINT BIOPHARMA GLOBAL INC COM | $8.6m1.85% | Unchanged |
| ULTRAGENYX PHARMACEUTICAL IN RARE | $8.5m1.82% | Unchanged |
| NOVA LTD NVMI | $8.2m1.76% | New |
| SPRINGWORKS THERAPEUTICS INC SWTX | $8.2m1.76% | Reduced -5.0k |
| SHL TELEMEDICINE LTD SHLT | $8.0m1.71% | New |
| TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS | $7.9m1.69% | Reduced -989.5k |
| ALNYLAM PHARMACEUTICALS INC ALNY | $7.6m1.63% | New |
| DISC MEDICINE INC IRON | $7.6m1.62% | Reduced -49.4k |
| ABBVIE INC ABBV | $7.5m1.62% | Reduced -7.0k |
| ELI LILLY & CO LLY | $7.4m1.58% | Reduced -16.0k |
| MERUS N V MRUS | $7.3m1.57% | Reduced -58.7k |
| IMMATICS N.V IMTX | $7.1m1.53% | Reduced -163.7k |
| MINERALYS THERAPEUTICS INC MLYS | $6.9m1.48% | Added +66.4k |
| PALO ALTO NETWORKS INC PANW | $6.9m1.48% | Added +7.0k |
| BIOGEN INC BIIB | $6.8m1.46% | Reduced -9.7k |
| CAMTEK LTD CAMT | $6.8m1.45% | Reduced -50.0k |
| KURA ONCOLOGY INC KURA | $6.4m1.37% | Unchanged |
| DAY ONE BIOPHARMACEUTICALS I COM | $6.3m1.36% | New |
| INOZYME PHARMA INC COM | $6.3m1.35% | Reduced -649.9k |
| TOWER SEMICONDUCTOR LTD TSEM | $6.3m1.35% | New |
| FUSION PHARMACEUTICALS INC COM | $6.2m1.33% | Added +45.7k |
| NOVARTIS AG NVS | $6.1m1.30% | Unchanged |
| SAGE THERAPEUTICS INC SAGE | $6.0m1.29% | Reduced -27.0k |
| JASPER THERAPEUTICS INC COM | $5.9m1.25% | Added +230.0k |
| MADRIGAL PHARMACEUTICALS INC MDGL | $5.8m1.24% | Added +6.0k |
| SAREPTA THERAPEUTICS INC SRPT | $5.7m1.23% | Added +6.0k |
| BRIDGEBIO PHARMA INC BBIO | $5.5m1.19% | Reduced -240.3k |
| CELLDEX THERAPEUTICS INC NEW CLDX | $5.4m1.16% | New |
| IVERIC BIO INC OPHT | $5.3m1.13% | Reduced -97.2k |
| MORPHIC HLDG INC MORF | $5.2m1.11% | New |
| PFIZER INC PFE | $5.1m1.10% | Unchanged |
| COGENT BIOSCIENCES INC COGT | $5.0m1.07% | Added +120.0k |
| KEZAR LIFE SCIENCES INC COM | $4.9m1.04% | Added +100.0k |
| ROCKET PHARMACEUTICALS INC RCKT | $4.7m1.01% | Unchanged |
| GRACELL BIOTECHNOLOGIES INC SPONSORED ADS | $4.7m1.00% | Reduced -1.1m |
| SPDR SER TR XBI | $4.2m0.89% | New |
| PTC THERAPEUTICS INC PTCT | $4.1m0.87% | Reduced -59.0k |
| ASTRIA THERAPEUTICS INC CATB | $3.9m0.84% | Added +50.0k |
| QUALCOMM INC QCOM | $3.8m0.82% | New |
| ENLIGHT RENEWABLE ENERGY LTD ENLT | $3.8m0.80% | Reduced -239.3k |
| GSK PLC GSK | $3.6m0.76% | New |
| TRAVERE THERAPEUTICS INC TVTX | $3.3m0.70% | Added +26.0k |
| GILEAD SCIENCES INC GILD | $3.1m0.66% | New |
| 89BIO INC ETNB | $2.6m0.55% | New |
| ARCELLX INC ACLX | $2.5m0.53% | Reduced -90.0k |
| REZOLUTE INC RZLT | $2.3m0.49% | Unchanged |
| SELECTA BIOSCIENCES INC COM | $2.3m0.49% | Reduced -286.5k |
| AMYLYX PHARMACEUTICALS INC AMLX | $2.2m0.46% | New |
| ALPINE IMMUNE SCIENCES INC NVLS | $2.1m0.44% | Unchanged |
| WEREWOLF THERAPEUTICS INC HOWL | $1.9m0.41% | Unchanged |
| ALTIMMUNE INC ALT | $1.8m0.38% | Added +200.0k |
| UNIQURE NV QURE | $1.7m0.37% | Added +86.7k |
| VERA THERAPEUTICS INC VERA | $1.7m0.36% | New |
| RIGEL PHARMACEUTICALS INC COM NEW | $1.6m0.34% | Reduced -650.7k |
| COMPUGEN LTD CGEN | $1.4m0.30% | New |
| MERSANA THERAPEUTICS INC COM | $1.4m0.30% | Added +407.9k |
| ELEVATION ONCOLOGY INC COM | $1.4m0.29% | New |
| DYNE THERAPEUTICS INC DYN | $1.3m0.29% | Reduced -99.4k |
| INHIBRX INC INBX | $1.3m0.28% | New |
| MEDIWOUND LTD MDWD | $1.2m0.25% | Unchanged |
| PMV PHARMACEUTICALS INC PMVP | $1.2m0.25% | Unchanged |
| IMMATICS N.V IMTXW | $342.0k0.07% | Unchanged |
| INFINITY PHARMACEUTICALS INC INFIQ | $310.7k0.07% | Unchanged |
| CYCLACEL PHARMACEUTICALS INC COM | $147.3k0.03% | Unchanged |
| ARBE ROBOTICS LTD ARBE | $124.7k0.03% | Unchanged |
Sold out since Q1 2023
| Security | Value then |
|---|---|
| NUTRIEN LTD NTR | $10.7m145.5k shares |
| INVESCO QQQ TR QQQ | $8.5m26.4k shares |
| BELLUS HEALTH INC NEW BLU | $5.8m799.9k shares |
| PERION NETWORK LTD PERI | $5.1m130.0k shares |
| KINIKSA PHARMACEUTICALS LTD | $4.8m450.3k shares |
| VAXCYTE INC PCVX | $3.4m90.0k shares |
| MIRUM PHARMACEUTICALS INC MIRM | $2.6m109.3k shares |
| AMGEN INC AMGN | $2.4m10.0k shares |
| CHINOOK THERAPEUTICS INC ADRO | $2.1m92.2k shares |
| CRINETICS PHARMACEUTICALS IN CRNX | $1.3m82.7k shares |
| KEROS THERAPEUTICS INC KROS | $1.3m30.1k shares |
| ANNEXON INC ANNX | $962.5k250.0k shares |
| REATA PHARMACEUTICALS INC RETA | $699.1k7.7k shares |
| FIVERR INTL LTD FVRR 0 11.01.25 | $208.2k250.0k shares |
| AEGLEA BIOTHERAPEUTICS INC AGLE | $187.5k646.5k shares |
| OTONOMO TECHNOLOGIES LTD | $186.4k391.9k shares |
| ONCORUS INC | $185.9k540.3k shares |
Options (notional value)
| Underlying | Notional | Change |
|---|---|---|
| TEVA PHARMACEUTICAL INDS LTD Call | $61.3m8.1m shares | Added |
| INVESCO QQQ TR QQQ · Put | $46.5m126.0k shares | New |
| ADVANCED MICRO DEVICES INC AMD · Call | $13.7m120.0k shares | New |
| TOWER SEMICONDUCTOR LTD TSEM · Put | $12.5m332.1k shares | New |
| SAREPTA THERAPEUTICS INC SRPT · Call | $9.0m78.3k shares | New |
| GENERAC HLDGS INC GNRC · Call | $7.8m52.5k shares | New |
| MICROSOFT CORP MSFT · Call | $7.2m21.0k shares | New |
| ENPHASE ENERGY INC ENPH · Call | $6.7m40.0k shares | New |
| ARGENX SE ARGX · Put | $3.9m10.0k shares | New |
| NICE LTD NICE · Call | $3.1m15.0k shares | New |
| BRIDGEBIO PHARMA INC BBIO · Call | $2.2m130.0k shares | Reduced |
Stakes above 5%
Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.
| Company | Stake |
|---|---|
| PROMIS NEUROSCIENCES INC PMN · 13G · filed 2026-02-05 | 7.8% |
| TENAX THERAPEUTICS INC TENX · 13G · filed 2026-10-13 | 7.1%≈ $38.8m |